Test Price
2,800 AED✅ Home Collection Available
PTPN11 Gene Noonan Syndrome Type 1 Genetic Test in UAE – DHA Licensed – DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy: 99.9% diagnostic sensitivity via ISO 15189 accredited next-generation sequencing (NGS) processing.
- Premium Logistics: VIP mobile phlebotomy with temperature-controlled cold-chain home collection across Dubai, Abu Dhabi, Sharjah, and all emirates.
- Clinical Guidance: Post-test telephonic clinical interpretation by DHA-licensed genetic counselors integrated with the report.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731 – check your coverage before booking.
Test Overview & Methodology
This comprehensive NGS test analyzes all coding exons of the PTPN11 gene to detect pathogenic variants associated with Noonan syndrome type 1 (OMIM #163950). Full-gene sequencing achieves 99.9% diagnostic sensitivity, identifying missense, nonsense, splice-site, and small indel variants with 1000× average read depth. Rigorous bioinformatics annotation and classification per ACMG/AMP guidelines ensure clinically actionable results.
| Parameter | DNA Labs UAE – PTPN11 Full Gene NGS | Conventional Hotspot Panel |
|---|---|---|
| Precision | Full gene sequencing, detection of deep intronic & novel variants | Limited to selected hotspot exons; misses variants outside target |
| Methodology | Next-Generation Sequencing (NGS) with 1000× read depth | Sanger sequencing with less than 200× coverage |
| Turnaround | 3–4 weeks (includes rigorous bioinformatics & clinical annotation) | 2–3 weeks but may require reflex NGS for inconclusive results |
Physician Insight & Safety Protocols
“As a clinical geneticist, I stress that PTPN11 test results must be interpreted in the context of full clinical evaluation, family history pedigree, and echocardiographic screening. This molecular test confirms the diagnosis but does not replace physical examination or growth chart monitoring. Pre- and post-test genetic counseling are essential to help families understand recurrence risks, surveillance protocols, and the potential need for oncological follow-up for juvenile myelomonocytic leukemia (JMML).”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory: Pre- and Post-Test Genetic Counseling
Genetic counseling is strongly recommended before and after the test to ensure informed consent, discuss potential implications for family members, and interpret results within the broader clinical context. This test is not a standalone diagnostic tool – always combine with echocardiography, growth parameters, and developmental assessment.
Exclusion Criteria
- Inability to provide informed consent – the patient or legal guardian must be capable of understanding the nature and implications of genetic testing.
- Uncooperative pediatric patient – if adequate phlebotomy preparation (e.g., proper vein access) cannot be achieved safely.
- Acute medical emergency – do not delay emergency care for elective genetic testing. If you experience chest pain, severe bleeding, or rapidly worsening symptoms, seek immediate emergency room attention.
- Medication warning: Do not discontinue any prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
1. What is the benefit of PTPN11 genetic testing for Noonan syndrome?
Identifying a pathogenic PTPN11 mutation confirms the clinical diagnosis of Noonan syndrome type 1, guides heart and growth monitoring, and triggers oncological surveillance for juvenile myelomonocytic leukemia (JMML). This enables early intervention, tailored surveillance, and informed family planning.
2. How long do PTPN11 gene test results take in the UAE?
The NGS wet-lab and bioinformatics pipeline requires 3–4 weeks to ensure 99.9% diagnostic accuracy with full clinical-grade variant interpretation, aligning with DHA quality standards and ACMG guidelines.
3. Is home sample collection available for this genetic test in Dubai?
Yes, our DHA-licensed phlebotomy team provides painless, hospital-grade home blood draw with temperature-controlled transport across Dubai, Abu Dhabi, Sharjah, and all emirates. Available daily from 8 AM to 11 PM.
UAE Regulatory & Data Privacy Adherence
Data Protection: Patient genetic data is handled in strict compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety & Consent: All testing and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring informed consent and clinical accountability.
Accreditation: DNA Labs UAE is DHA-licensed (Facility License #1143) and operates under ISO 15189 quality standards for medical laboratories.
Clinical & Logistical Metadata
| Test Name | PTPN11 Gene Noonan Syndrome Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene coding exons |
| ICD-10-CM Code | Q87.1 (Noonan syndrome) |
| LOINC Code | 94833-5 (PTPN11 gene mutation analysis in Blood or Tissue by Sequencing) |
| DHA Facility License & Address | License #1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians